ARSA Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 53.6 kDa observed
Observed band 53.6 kDa observed
Gel 12-15%
Positive control Cerebellum
Negative control Use knockout/knockdown or orthogonal negative
Important caveats
Reasons your observed band may differ from the expected size.
Calculated mass53.6 kDa
LocalizationEndoplasmic reticulum / Lysosome
Processing / PTMRecord-dependent
ReactivityHuman / Mouse / Rat
Section 1

Real Curated ARSA Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdrenal gland
Gel %12-15%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryM02583 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected ARSA Western Blot Band Size?

Use the product-observed 53.6 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
53.6 kDaMatches the authoritative product WB observation.
53.6 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected ARSA appearancePlan around 53.6 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band53.6 kDa; use this as the primary experimental expectation.
Calculated mass53.6 kDa from UniProt P15289; retain as context.
Gel selection12-15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with M02583.
Why is my band missing or off?
SituationLikely causeNext action
53.6 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for ARSA Western blot

🧪Use Cerebellum as the first positive-control candidate and retain an orthogonal negative control.
Positive control: Cerebellum (High)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for ARSA

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue Cell type Level Evidence Source
Cerebellum Reported tissue cells High Protein (HPA) HPA →
Gallbladder Reported tissue cells High Protein (HPA) HPA →
Colon Reported tissue cells High Protein (HPA) HPA →
Adrenal gland Reported tissue cells High Protein (HPA) HPA →
Bone marrow Reported tissue cells Low Protein (HPA) HPA →
Oral mucosa Reported tissue cells Low Protein (HPA) HPA →

Undetected expression · recommended negative controls

The available HPA profile lists no reliably-negative tissue for ARSA (a broadly-expressed target). Use a ARSA knockdown (siRNA/shRNA) or knockout lysate as the negative control and confirm signal loss versus the parental lysate.
Tissue Cell type Level Evidence Source
Section 3

Advanced ARSA Western Blot Tips

Deeper troubleshooting and optimisation questions for ARSA, answered from its protein features.

Which band should guide the blot?
Use 53.6 kDa, the observation attached to the authoritative M02583 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 53.6 kDa expectation.
Which positive control should I start with?
Start with Cerebellum, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use a target knockdown/knockout control when no HPA Not detected tissue is available.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for ARSA Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should M02583 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

ARSA Western Blot Reagents

Human/Mouse/Rat-reactive ARSA Western blot reagents with authoritative product imagery.

Real WB dataWestern blot validation image for ARSA using M02583; observed band 53.6 kDa
Anti-ARSA Antibody Picoband® (monoclonal, 4C10)
Cat # M02583
Real WB dataWestern blot validation image for ARSA using PB9477; observed band 53.6 kDa
Anti-ARSA Antibody Picoband®
Cat # PB9477

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.